cancer-treatment

Documents about cancer-treatment

• Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma#213272HAL (France)
• SHAP-based interpretable machine learning with longitudinal delta-radiomics across seven weeks of treatment for xerostomia prediction in head-and-neck cancer.#239725NCBI PubMed Central
• Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.#244232NCBI PubMed Central
• New data on opioid use disorder and risk of overdose in adolescent and young adult disease-free survivors prescribed opioids after cancer treatment.#247524NCBI PubMed Central
• Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study#261501ClinicalTrials.gov
• Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#261503ClinicalTrials.gov
• PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)#405141ClinicalTrials.gov
• Health care access domains and treatment as mediators of ovarian cancer racial disparities in survival: a structural equation modeling analysis in SEER-Medicare.#430952NCBI PubMed Central
• Photodynamic therapy based on indomethacin-conjugated photosensitizers: targeting cyclooxygenase-2 in cancer treatment#676330Europe PMC
• Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis#802517ClinicalTrials.gov
• Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study#810568ClinicalTrials.gov
• Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer#407741ClinicalTrials.gov
• SMMART Adaptive Clinical Treatment (ACT) Trial#805987ClinicalTrials.gov
• A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus#807161ClinicalTrials.gov
• A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma#152407ClinicalTrials.gov
• Validating cancer-specific and generic quality of life (QoL) instruments among patients with head and neck cancers: incorporating the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck Module with generic QoL instruments.#288616NCBI PubMed Central
• Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial#807323ClinicalTrials.gov
• Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC#174860ClinicalTrials.gov
• Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma#217027ClinicalTrials.gov
• Treatment Response in Advanced and Metastatic Esophageal Cancer Patients on Palliative Treatments in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: A Retrospective Study#231381Europe PMC
• Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment#240332Ora Oxford University Research
• A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.#261514ClinicalTrials.gov
• Effectiveness of RMSSD-Based Adaptive Music Therapy (Skitii) in Reducing Treatment-Related Anxiety in Head and Neck Cancer Patients: Protocol for a Randomized Controlled Trial#271996bioRxiv / medRxiv
• EGFR Exon 20 Insertion–Mutated Non-Small Cell Lung Cancer: Current Treatment Landscape and Future Directions#306093Springer Nature OA
• Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma#314351ClinicalTrials.gov
• Patient-reported distress and correlates while on adjuvant endocrine therapy following breast cancer treatment among post-menopausal women: a group-based trajectory model analysis.#317626NCBI PubMed Central
• Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool#350761HAL (France)
• Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records.#368116NCBI PubMed Central
• Effect of treatment interruptions and outcomes in cancer patients undergoing radiotherapy during the first wave of COVID-19 pandemic in a tertiary care institute#376092PubMed Central
• Navigating ethical challenges in the FORTEe randomised controlled trial : a multi-centre staff survey on exercise intervention for children and adolescents undergoing cancer treatment#379322The Learning Edge
• Supportive care needs among head and neck cancer patients in the recovery phase from 6 months to 2 years after treatment: which factors matter?#380926NCBI PubMed Central
• Access to And Utilisation of Nuclear Medicine Services in University College Hospital, Ibadan, Nigeria#687077University of Ibadan Institutional Repository
• The change in epidemiological characteristics and utilization of health services for the diagnosis and treatment of colorectal cancer: A hospital-based retrospective survey.#796700NCBI PubMed Central
• Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer#802854ClinicalTrials.gov
• DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma#805117ClinicalTrials.gov
• The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease#810426ClinicalTrials.gov
• First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)#159265HAL (France)
• Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)#314328ClinicalTrials.gov
• Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study#121359ClinicalTrials.gov
• Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study#146466ClinicalTrials.gov
• Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma#148765ClinicalTrials.gov
• Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.#172326ClinicalTrials.gov
• Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC#195323ClinicalTrials.gov
• Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma#195326ClinicalTrials.gov
• Is there a role for adjuvant radiotherapy after partial laryngectomy? A propensity score matched analysis#247026IRIS
• HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer#256872ClinicalTrials.gov
• Computational biology dynamics of Mps1 Kinase molecular interactions with isoflavones reveals a chemical scaffold with potential to develop new therapeutics for the treatment of cancer#289727The Learning Edge
• Neurodiversity-Affirming Principles in Oncology Treatment: A Lived-Experience Case Study.#290779Apollo
• Therapeutic potential of bovine colostrum- and milk-derived exosomes in cancer prevention and treatment: mechanisms, evidence, and future perspectives#325988HAL (France)
• Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN#332739ClinicalTrials.gov